Imunon (FRA:CBO0) Insider Ownership: 0.00 % (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CBO0 Imunon Inc FRA:CBO0
37 GF Score
Price €1.12
GF Value €5.35
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Imunon Insider Ownership?

Imunon FRA:CBO0 -4.27% 37 Insider Ownership is 0.00 % as of Sep. 16, 2026. GuruFocus rates FRA:CBO0 with a GF Score™ of 37/100 and a GF Value™ of €5.35 (Possible Value Trap). The stock has 3 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Imunon's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Imunon's Institutional Ownership is 0.96%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Imunon's Float Percentage Of Total Shares Outstanding is 99.57%.

Imunon Insider Ownership Historical Data

* Premium members only.

The historical data trend for Imunon's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imunon Insider Ownership Chart

Imunon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Insider Ownership
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Imunon Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:CBO0
37GF Score
Imunon Inc FRA:CBO0
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imunon Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.00 % mean?
Imunon (FRA:CBO0) has a Insider Ownership of 0.00 % as of Sep. 16, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Imunon and its competitors.
Is Imunon's Insider Ownership too high?
Imunon's current Insider Ownership is 0.00 %. Overall, Imunon has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Imunon's Insider Ownership compare to TRAW and OSRH?
Imunon's Insider Ownership of 0.00 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Imunon and its competitors. Imunon's current Insider Ownership is 0.00 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imunon stock overvalued right now?
Based on GuruFocus' analysis, Imunon (FRA:CBO0) is currently considered Possible Value Trap. The stock's GF Value™ is €5.35, compared to a current price of €1.12 — trading 79.1% below its estimated fair value. The current Insider Ownership is 0.00 %. Imunon's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Imunon (FRA:CBO0), the current Insider Ownership is 0.00 % as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imunon (FRA:CBO0) Overvalued in 2026?

Based on GuruFocus' analysis, Imunon stock appears to be undervalued. The current stock price of €1.12 is trading 79.1% below its estimated GF Value™ of €5.35. GuruFocus considers Imunon to be Possible Value Trap.

Key valuation signals for FRA:CBO0:

  • Insider Ownership: 0.00 %
  • GF Value™: €5.35 vs. price of €1.12 (79.1% below fair value)
  • GF Score™: 37/100 with 3 warning signs

No single metric tells the full story. See the FRA:CBO0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Imunon Business Description

Other Exchanges IMNN:USACBO0:Germany
Address 997 Lenox Drive, Suite 100, Lawrenceville, NJ, USA, 08648
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
37GF Score

Get the complete analysis for FRA:CBO0

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.12
Price
€5.35
GF Value